Cargando…

Clinical ocular manifestations of Taiwanese patients with mucopolysaccharidoses VI (Maroteaux–Lamy syndrome)

Mucopolysaccharidoses (MPS) is a group of lysosomal storage disorders that lead to accumulation of glycosaminoglycans (GAGs) in many tissues and organs, resulting in different clinical features. In this study, we conducted the manifestation changes of refractive error, corneal clouding, and intraocu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hsu-Ying, Huang, You-Hsin, Lei, Shao-Yu, Chen, Lee-Jen, Lin, Shuan-Pei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759551/ https://www.ncbi.nlm.nih.gov/pubmed/31572657 http://dx.doi.org/10.4103/tjo.tjo_85_17

Ejemplares similares

Hemifacial Spasm in Mucopolysaccharidosis Type VI (Maroteaux–Lamy Syndrome)
por: Karir, Aneesh, et al.
Publicado: (2018)

Fundoscopic Changes in Maroteaux-Lamy Syndrome
por: Magalhães, Augusto, et al.
Publicado: (2019)

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) in the pre-Columbian culture of Colombia
por: Pachajoa, Harry, et al.
Publicado: (2014)

Molecular findings of Colombian patients with type VI mucopolysaccharidosis (Maroteaux–Lamy syndrome)
por: Giraldo, Gustavo Adolfo, et al.
Publicado: (2015)

Airway hitches and management in Maroteaux-Lamy syndrome
por: Kamat, Uma, et al.
Publicado: (2022)

Sensory-motor behavioral characterization of an animal model of Maroteaux-Lamy syndrome (or Mucopolysaccharidosis VI)
por: Saccone, Paola, et al.
Publicado: (2014)

Atlantoaxial instability in a case of Maroteaux–Lamy syndrome
por: Shah, Abhidha, et al.
Publicado: (2021)

Ophthalmologic manifestations in Taiwanese patients with mucopolysaccharidoses
por: Lin, Hsiang‐Yu, et al.
Publicado: (2019)

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): defining and measuring functional impacts in pediatric patients
por: Leiro, Beth, et al.
Publicado: (2021)

Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux–Lamy syndrome): under-recognized and challenging to diagnose
por: Lachman, Ralph S., et al.
Publicado: (2014)

A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase
por: El Dib, Regina P, et al.
Publicado: (2009)

Multiple Dentigerous Cysts as a Rare Presentation of Maroteaux–Lamy Syndrome
por: Shah, Ajaz Ahmad, et al.
Publicado: (2017)

Fifteen years of enzyme replacement therapy for mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome): a case report
por: Andrade, Isadora, et al.
Publicado: (2022)

Anesthesia in a child with Maroteaux-Lamy syndrome undergoing mitral valve replacement
por: Sayilgan, Cem, et al.
Publicado: (2012)

Long-term cognitive follow-up in children treated for Maroteaux-Lamy syndrome
por: Ebbink, Berendine J., et al.
Publicado: (2015)

Functional independence of Taiwanese patients with mucopolysaccharidoses
por: Lee, Chung‐Lin, et al.
Publicado: (2019)

Home treatment of type VI mucopolysaccharidosis (Maroteaux‐Lamy syndrome) an alternative at this time of COVID‐19 pandemic: A case in Peru
por: Cortez Miranda, Jenny Lucy, et al.
Publicado: (2020)

Double valve replacement in a patient with Maroteaux – Lamy syndrome as an ultimate team challenge
por: Demis, Alexandros Agron, et al.
Publicado: (2021)

Otorhinolaryngological Management in Taiwanese Patients with Mucopolysaccharidoses
por: Lee, Chung-Lin, et al.
Publicado: (2021)

Illness Perception and Clinical Treatment Experiences in Patients with M. Maroteaux-Lamy (Mucopolysaccharidosis Type VI) and a Turkish Migration Background in Germany
por: Dilger, Hansjörg, et al.
Publicado: (2013)

Updated Confirmatory Diagnosis for Mucopolysaccharidoses in Taiwanese Infants and the Application of Gene Variants
por: Chuang, Chih-Kuang, et al.
Publicado: (2022)

Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985–2019)
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)

Relationships among Height, Weight, Body Mass Index, and Age in Taiwanese Children with Different Types of Mucopolysaccharidoses
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)

Cardiac Evaluation Using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with Mucopolysaccharidoses
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)

Lamy fiscal
por: Bonafoux, Philippe
Publicado: (1990)

Lamy fiscal
por: Bonafoux, Philippe
Publicado: (1990)

Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses
por: Fenzl, Carlton R, et al.
Publicado: (2015)

The Anesthetic Strategy for Patients with Mucopolysaccharidoses: A Retrospective Cohort Study
por: Lao, Hsuan-Chih, et al.
Publicado: (2022)

Assessing the impact of the five senses on quality of life in mucopolysaccharidoses
por: Giugliani, Roberto, et al.
Publicado: (2020)

The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidoses
por: Lin, Hsiang‐Yu, et al.
Publicado: (2018)

Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan
por: Chuang, Chih-Kuang, et al.
Publicado: (2018)

Management of otolaryngological manifestations in mucopolysaccharidoses: our experience
por: MESOLELLA, M., et al.
Publicado: (2013)

Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series
por: Lin, Hsiang-Yu, et al.
Publicado: (2016)

A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses
por: Chuang, Chih-Kuang, et al.
Publicado: (2014)

Assessment of bone mineral density by dual energy x-ray absorptiometry in patients with mucopolysaccharidoses
por: Lin, Hsiang-Yu, et al.
Publicado: (2013)

An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

RUNX2 mutations in Taiwanese patients with cleidocranial dysplasia
por: Lin, Wei-De, et al.
Publicado: (2011)

Llivre de L'ami et de l'aimé /
por: Llull, Ramon, 1232?-1316

ENT and mucopolysaccharidoses
por: Bianchi, Pier Marco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dbbh4n4vtob7i1t5bi8p0bp2on